VentureHealth is an online venture fund platform for accredited investors who want access to breakthrough opportunities in the $2.5 trillion US healthcare sector.
Based in Silicon Valley, the firm was founded by professional investors with strong track records, who are passionate about improving healthcare. The team vets investments based on its deep experience in company building, and is incentivized by the quality of deals, not quantity.
Venturehealth is open to accredited investors who understand and care about clinical outcomes. Its minimum investment size varies by transaction.
Venturehealth focuses on privately-held, young companies with strong intellectual property that are focused on commercializing a breakthrough innovation in healthcare. Some issuers will already have attracted venture capital investors; others may be seeking their first round of outside capital. Most ventures will be developing clinically-focused innovations that are regulated by the FDA, and that will need to be paid for by the reimbursement system in the USA.
An example of a Venturehealth transaction:
Let’s say there’s a biomedical breakthrough that could dramatically improve clinical outcomes. Maybe it’s a cure for epilepsy, a new treatment for cancer, or a way to treat refractory, chronic pain. The science is sound, the team is credible and the patient population will benefit dramatically; you want to invest. – VentureHealth
Mir Imran founded InCube Labs, a multi-disciplinary research lab, and InCube Ventures, a life sciences venture fund, to focus on his passion: creating medical solutions that change the standard of care in critical healthcare markets. Mir began his career as a med-tech entrepreneur in the late 1970's and has founded numerous game-changing companies since those early days. Over the decades, he has become one of the leading inventors and entrepreneurs in healthcare. Mir now holds more than 200 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator, a device sold to Eli Lilly and is now part of Guidant. Additionally, Mir has invented a number of breakthrough devices that set new standards of care for their industries. As an entrepreneur, Mir has founded more than 20 medical device companies; 15 of his companies have seen "liquidity events" (IPO/Acquisition). Mir currently holds board seats with Bodymedia, Corhythm, eGeen, Entrack, Fe3, Intrapace, Modulus, Neurolink, NFocus, and Spinal Modulation. Mir is also Chairman and CEO of InCube Labs and Modulus Inc., a manufacturing and product development company focused on the medical device market. For more information on Mir and his companies, go to www.incubelabs.com and www.modulusinc.com.
Before understanding what crowdfunding could do for biotech, its important to understand how big
We recently introduced you to VentureHealth, an online venture fund that connects accredited investors with biotech startups. Today we feature the second part of our conversation with VentureHealth co-founder Talat Imran, who also serves as the platfor …
All of us in the equity crowdfunding field see the power of connecting smart, passionate capital to promising companies. But the business models employed to achieve this promise will dramatically affect the outcomes for investors. Although the field of …
As life science funding slows to meagre trickle, VentureHealth is trying to speed it back up. VentureHealth has launched its online equity crowdfunding platform for life sciences companies. It provides accredited investors with opportunities to invest …